List view / Grid view

Mikael Dolsten

 

news

Pfizer to acquire Excaliard Pharmaceuticals

Lead program includes novel investigational compound for prevention/treatment of skin…

22 November 2011 | By Pfizer

Lead program includes novel investigational compound for prevention/treatment of skin scarring...